AU2046101A - Preservation and formulation of bioactive materials for storage and delivery in hydrophobic carriers - Google Patents

Preservation and formulation of bioactive materials for storage and delivery in hydrophobic carriers

Info

Publication number
AU2046101A
AU2046101A AU20461/01A AU2046101A AU2046101A AU 2046101 A AU2046101 A AU 2046101A AU 20461/01 A AU20461/01 A AU 20461/01A AU 2046101 A AU2046101 A AU 2046101A AU 2046101 A AU2046101 A AU 2046101A
Authority
AU
Australia
Prior art keywords
preservation
formulation
delivery
storage
bioactive materials
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU20461/01A
Inventor
Victor Bronshtein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universal Preservation Technologies Inc
Original Assignee
Universal Preservation Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universal Preservation Technologies Inc filed Critical Universal Preservation Technologies Inc
Publication of AU2046101A publication Critical patent/AU2046101A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04—Preserving or maintaining viable microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
AU20461/01A 1999-11-22 2000-11-22 Preservation and formulation of bioactive materials for storage and delivery in hydrophobic carriers Abandoned AU2046101A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16678399P 1999-11-22 1999-11-22
US60166783 1999-11-22
PCT/US2000/032071 WO2001037804A2 (en) 1999-11-22 2000-11-22 Preservation and formulation of bioactive materials

Publications (1)

Publication Number Publication Date
AU2046101A true AU2046101A (en) 2001-06-04

Family

ID=22604686

Family Applications (1)

Application Number Title Priority Date Filing Date
AU20461/01A Abandoned AU2046101A (en) 1999-11-22 2000-11-22 Preservation and formulation of bioactive materials for storage and delivery in hydrophobic carriers

Country Status (2)

Country Link
AU (1) AU2046101A (en)
WO (1) WO2001037804A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002251931B2 (en) * 2001-02-16 2007-01-04 Cambridge Biostability Ltd Composition and method for controlled release injections

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000062759A1 (en) 1999-04-16 2000-10-26 Novo Nordisk A/S Dry, mouldable drug formulation
CA2482448C (en) * 2002-04-11 2014-07-08 Medimmune Vaccines, Inc. Preservation of bioactive materials by freeze dried foam
GB0408199D0 (en) * 2004-04-13 2004-05-19 Cambridge Biostability Ltd Liquids containing suspended sugar glass particles
JP2007532619A (en) * 2004-04-13 2007-11-15 ケンブリッジ バイオスタビリティ リミテッド Liquid containing suspended glass particles
US9744227B2 (en) * 2004-06-02 2017-08-29 Universal Stabilization Technologies, Inc. Compositions containing ambient-temperature stable, inactivated but therapeutically active biopharmaceuticals and methods for formulation thereof
WO2013188626A2 (en) * 2012-06-15 2013-12-19 Dow Global Technologies Llc Probiotic-containing particles having improved probiotic stability when in aqueous formulations
EP4026568A1 (en) 2015-04-17 2022-07-13 CureVac Real Estate GmbH Lyophilization of rna
EP3298142B1 (en) 2015-05-20 2021-07-14 CureVac AG Dry powder composition comprising long-chain rna
CN107530448A (en) 2015-05-20 2018-01-02 库瑞瓦格股份公司 Include long-chain RNA dry powder composite
CN107897170A (en) * 2017-11-17 2018-04-13 南京普维康生物科技有限公司 A kind of buccal swab DNA preservation solution and preparation method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5766520A (en) * 1996-07-15 1998-06-16 Universal Preservation Technologies, Inc. Preservation by foam formation
IN184589B (en) * 1996-10-16 2000-09-09 Alza Corp
GB9705588D0 (en) * 1997-03-18 1997-05-07 Anglia Research Foundation Stable particle in liquid formulations

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002251931B2 (en) * 2001-02-16 2007-01-04 Cambridge Biostability Ltd Composition and method for controlled release injections

Also Published As

Publication number Publication date
WO2001037804A2 (en) 2001-05-31
WO2001037804A3 (en) 2001-11-22

Similar Documents

Publication Publication Date Title
AU1798101A (en) Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
AU5446300A (en) Heat retentive food storage/delivery container and system
AU1790301A (en) In ovo delivery of an immunogen containing implant
AU6597098A (en) Transport and storage container for liquids
GB0005839D0 (en) Storage and delivery of micro-organisms
AU4303600A (en) Pharmaceutical composition in unit form containing acetylsalcylic acid and clopidogrel hydrogenosulphate
HUP0203575A3 (en) Pharmaceutical compositions containing th2 differentiation inhibitors and their use
AU2046101A (en) Preservation and formulation of bioactive materials for storage and delivery in hydrophobic carriers
AU2001250027A1 (en) Apparatus for transport and delivery of articles
EP1067130A4 (en) Triazolo derivatives and chemokine inhibitors containing the same as the active ingredient
PL326526A1 (en) Compositions of controllable release of active substances contained in them
AU6804798A (en) Transport and storage container for liquids
AU3135895A (en) Dispensing pump which is lockable and sealable for transportation and storage
AU5715700A (en) Plastic container for the transportation and/or storage of goods
AU5534496A (en) Vacuum storage and dispensing container
IL134001A0 (en) Active oxygen scavenger compositions and their use in packaging articles
EP0960885A4 (en) Depsipeptides and drugs containing the same as the active ingredient
AU1650401A (en) Oxadiazole derivatives and drugs containing these derivatives as the active ingredient
AU2283301A (en) Bulk mail container unloading system and method
GB0201798D0 (en) Multiple use storage and transport container
IL138841A (en) Composition in the form of extruded granules containing an organosilicone surfactant and an active ingredient
HUP0004223A3 (en) 4-oxo-butynic acids and pharmaceutical composition containing them as active agent
AUPP990299A0 (en) Storage and transportation device
AU4400300A (en) Transport and storage container with inward-folding side walls
AU5397300A (en) Pharmaceutical composition for intranasal use of active substances that are insoluble and/or hardly soluble in water

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase